Table 2 Treatment data by group
Variable | Level | TNBC (n = 130) | MBC (n = 44) | Total | p value |
|---|---|---|---|---|---|
Local therapy | None | 4 (3.1%) | 1 (2.3%) | 5 (2.9%) | 0.8203 |
Complete mastectomy | 33 (25.4%) | 15 (34.1%) | 48 (27.6%) | — | |
Lumpectomy | 2 (1.5%) | 1 (2.3%) | 3 (1.7%) | — | |
Radiation therapy | 2 (1.5%) | 0 (0.0%) | 2 (1.1%) | — | |
Complete mastectomy + radiation therapy | 37 (28.5%) | 13 (29.5%) | 50 (28.7%) | — | |
Lumpectomy + radiation therapy | 52 (40.0%) | 14 (31.8%) | 66 (37.9%) | — | |
Radiation | Yes | 91 (70.0%) | 27 (61.4%) | 118 (67.8%) | 0.3509 |
Breast conserving surgery | Yes | 54 (41.5%) | 15 (34.1%) | 69 (39.7%) | 0.4763 |
Chemotherapy in first year following diagnosis | Yes | 119 (91.5%) | 38 (86.4%) | 157 (90.2%) | 0.3782 |
Anthracycline therapy | Yes | 104 (80.0%) | 34 (77.3%) | 138 (79.3%) | 0.6731 |
Platinum therapy | Yes | 17 (13.1%) | 6 (13.6%) | 23 (13.2%) | 1.0000 |
Taxane therapy | Yes | 111 (85.4%) | 31 (70.5%) | 142 (81.6%) | 0.0411 |